Zobrazeno 1 - 7
of 7
pro vyhledávání: '"A. Klagou"'
Autor:
Fanouriakis, Antonis, Adamichou, Christina, Koutsoviti, Sofia, Panopoulos, Stylianos, Staveri, Chrysanthi, Klagou, Anastasia, Tsalapaki, Christina, Pantazi, Lamprini, Konsta, Styliani, Mavragani, Clio P., Dimopoulou, Despoina, Ntali, Styliani, Katsikas, Georgios, Boki, Kyriaki A., Vassilopoulos, Dimitrios, Konstantopoulou, Pinelopi, Liossis, Stamatis-Nick, Elezoglou, Antonia, Tektonidou, Maria, Sidiropoulos, Prodromos, Erden, Abdulsamet, Sfikakis, Petros P., Bertsias, George, Boumpas, Dimitrios T.
Publikováno v:
In Seminars in Arthritis and Rheumatism December 2018 48(3):467-474
Autor:
Demirtzoglou, Georgios, Theodorou, Evangelos, Klagou, Anastasia, Zervos, Nikolaos, Ampatziadis, Efstathios
Background: Ankylosing spondylitis, is a chronic inflammatory autoimmune disease that mainly affects spine joints. It can cause severe, chronic pain, spine fusion and chronic disability. Ehlers-Danlos syndrome is a rare heterogenous group of heredita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fa970830bd1fad6403e7243f962547b
Autor:
Clio P. Mavragani, Antonia Elezoglou, Lamprini Pantazi, Stylianos Panopoulos, Petros P. Sfikakis, Anastasia Klagou, Christina Tsalapaki, Dimitrios Vassilopoulos, Prodromos Sidiropoulos, Kyriaki A. Boki, Abdulsamet Erden, Styliani Konsta, D. Dimopoulou, Styliani Ntali, Georgios Katsikas, George Bertsias, Pinelopi Konstantopoulou, Antonis Fanouriakis, Dimitrios T. Boumpas, Christina Adamichou, Stamatis-Nick C. Liossis, Sofia Koutsoviti, Maria G Tektonidou, Chrysanthi Staveri
Publikováno v:
Seminars in Arthritis and Rheumatism. 48:467-474
Background Low disease activity is a validated target of current systemic lupus erythematosus (SLE) therapy. The aim of this study was to assess the ability of belimumab to achieve low disease activity states in real-life settings. Methods Multicentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae91cd037b0d567ad68a1063d82f04d9
https://doi.org/10.1016/j.semarthrit.2018.02.014
https://doi.org/10.1016/j.semarthrit.2018.02.014
Autor:
S. Konsta, L. Pantazi, A. Klagou, D. Dimopoulou, A. Fanouriakis, G. Bertsias, P.P. Sfikakis, Maria G Tektonidou, P. Konstantopoulou, Dimitrios Vassilopoulos, Christina Adamichou, Kyriaki A. Boki, S.-N. Liossis, Georgios Katsikas, Christina Tsalapaki, A. Erden, S. Ntali, Dimitrios T. Boumpas, Prodromos Sidiropoulos, S. Koutsoviti, Stylianos Panopoulos, C. Staveri, Clio P. Mavragani, Antonia Elezoglou
Publikováno v:
FRIDAY, 15 JUNE 2018.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9de20653d48fc36b1a61e27d1a0a7b38
https://doi.org/10.1136/annrheumdis-2018-eular.5259
https://doi.org/10.1136/annrheumdis-2018-eular.5259
Background: Low disease activity is a validated target of current systemic lupus erythematosus (SLE) therapy. The aim of this study was to assess the ability of belimumab to achieve low disease activity states in real-life settings. Methods: Multicen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::902130cb2a4cbf93e27458b093a3ad8a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122899
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122899
Autor:
Prodromos Sidiropoulos, D. Dimopoulou, A. Erden, Christina Adamichou, A. Klagou, Christina Tsalapaki, Dimitrios Vassilopoulos, Dimitrios T. Boumpas, S. Ntali, A. Fanouriakis, S. Konsta, Antonia Elezoglou, G. Bertsias, P. Konstantopoulou, S. Koutsoviti
Publikováno v:
Abstracts Accepted for Publication.
Background Data on the efficacy of belimumab in SLE mainly originate from large randomized clinical trials, whereas reports from real-life clinical practice are lacking. Objectives To describe the clinical experience from the use of belimumab in Gree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3752c1abf74386c3a59854cf1d6d9c3
https://doi.org/10.1136/annrheumdis-2017-eular.4825
https://doi.org/10.1136/annrheumdis-2017-eular.4825
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.